查詢結果分析
相關文獻
- Sofosbuvir/velpatasvir/voxilaprevir Plus Ribavirin for Chronic Hepatitis C Patients with Direct Acting Antiviral Failures: Implications for Viral Elimination in Taiwan
- Sofosbuvir慢性C型肝炎全口服治療新藥
- 第一型慢性C型肝炎全口服治療新藥Ledipasvir/Sofosbuvir (Harvoni®)
- Sofosbuvir併用Amiodarone可能導致嚴重心搏過緩
- Resistance-associated Substitution and Ledipasvir/sofosbuvir Therapy in Mongolian Chronic Hepatitis C Patients
頁籤選單縮合
題 名 | Sofosbuvir/velpatasvir/voxilaprevir Plus Ribavirin for Chronic Hepatitis C Patients with Direct Acting Antiviral Failures: Implications for Viral Elimination in Taiwan |
---|---|
作 者 | Liu, Chen-hua; Su, Tung-hung; Liu, Chun-jen; Chen, Pei-jer; Chen, Ding-shinn; Kao, Jia-horng; | 書刊名 | Journal of the Formosan Medical Association |
卷 期 | 119:12 2020.12[民109.12] |
頁 次 | 頁1871-1875 |
分類號 | 418.285 |
關鍵詞 | Hepatitis C virus; Direct acting antiviral; Sofosbuvir; Velpatasvir; Voxilaprevir; |
語 文 | 英文(English) |